Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Equipment
Datasets
Search by expertise, name or affiliation
Prot# APD371-202: A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of Olorinab in Subjects with Irritable Bowel Syndrome Experiencing Abdominal Pain
Brenner, Darren M
(PD/PI)
Medicine, Gastroenterology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
5/8/20
→
5/8/23
Funding
DrugDev Inc.
(Prot# APD371-202)
Arena Pharmaceuticals, Inc.
(Prot# APD371-202)
View all
View less